This podcast briefly reviews the historical gastric cancer classifications and explains how this has drastically changed over the past 5-10 years with the advent of next-generation...
Drs David Ilson and Robert Figlin discuss recent clinical advances in colon and rectal cancer from ASCO20 Virtual.
Geoffrey Ku, MD, and Robert Figlin, MD, discuss recent clinical developments in gastric and esophageal cancer.
This week the discussion surrounds the efficacy of the combination of lenvatinib and pembrolizumab for patients with advanced gastric cancer.
Drs Hofland and Massacesi discuss the company’s partnerships with Daiichi Sankyo in developing a very targeted drug for the treatment of patients with HER2+ advanced gastric cancer.
Form 1 of the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale serves to grade therapies with curative intent.